Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

This study has been terminated.
Information provided by:
Titan Pharmaceuticals Identifier:
First received: December 17, 2002
Last updated: January 21, 2011
Last verified: November 2006
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2005
  Primary Completion Date: March 2005 (Final data collection date for primary outcome measure)